



The DNA methylation machinery 
 





Cytosine methylation is an important epigenetic signalling mechanism that 
regulates gene expression. The presence of 5-methylcytosine (5-mC) at 
promoters is associated with gene silencing. In this chapter, we will describe 
our current understanding of;  
i) The mechanisms and molecules involved in the addition, and 
maintenance, of methyl groups to cytosine bases (5-mC writers). 
ii) The mechanism by which these 5-mC modifications are read 
resulting in changes in gene expression. 
iii) The molecules and mechanisms involved in removing methyl groups 










1. DNA Methylation / Methylcytosine  
In eukaryotic cells, the addition of methyl groups (CH3) to DNA occurs almost 
exclusively on cytosine bases, more specifically at cytosines that are found directly 5′ 
to a guanine forming a CpG dinucleotide (Figure 1A). Methylation occurs at the 5th 
atom of the 6-atom ring (Figure 1B) resulting in the formation of 5-methylcytosine (5-
mC). On double stranded DNA, a CpG dinucleotide on one DNA strand will bind to a 
complementary CpG dinucleotide on the opposite DNA strand. If a cytosine on one 
DNA strand is methylated then its opposite counterpart will also be methylated 
(Figure 1A; see Chapter 3 - Methylcytosine and its oxidised derivatives for further 
details). 5-mC behaves in the same way as unmethylated cytosine; it binds to 
guanine in double stranded DNA (dsDNA) and acts as the complementary base for 
guanine during transcription (not changing the genetic function of DNA is a defining 
feature of an epigenetic modification). 
In humans, and other mammals, most CpG dinucleotides contain methylated 
cytosine (5-mC) and these methylated CpGs are distributed sparsely throughout the 
genome (Ziller et al. 2013). They are found at a low frequency in gene body regions 
and more densely at endogenous repeats and transposable elements (Bird 2002). 
The presence of 5-mC in gene body regions is associated with high levels of gene 
transcription while, the more densely occurring 5-mC found at transposable 
elements, such as LINE-1, suppresses transcription and mobility (Schulz et al. 
2006). Throughout the mammalian genome CpG dinucleotides are relatively rare 
due to the spontaneous deamination of 5-mC to thymine (Lander et al. 2001) (Figure 
2). However, unmethylated CpG dinucleotides are more abundant in regions called 
CpG islands. These range in size from about 300bp to 3kb in length and can be 
found at the promoter region, often encompassing the first exon, of approximately 
3 
 
70% of all human genes (Figure 3). There are approximately 27,000 CpG islands 
found in the non-repetitive regions of the human genome (Rollins et al. 2005; 
Saxonov et al. 2006; Deaton and Bird 2011). 
The expression pattern of genes determines the phenotype of cells, and which 
genes are expressed in a cell is principally determined by two factors:  
1). Gene expression is regulated by the binding of appropriate (lineage-specific) 
transcription factors (TFs) at the promoter region. These TFs are required to recruit 
RNA polymerase to the start of transcribed gene regions. The presence of cell 
specific transcription factors is determined during embryogenesis and is also 
regulated via cell signalling (Spitz and Furlong 2012). 
2). For transcription factors and RNA polymerase to bind to gene promoter regions 
the chromatin (DNA and associated proteins) at that region must be in an 
uncondensed state, that is, the number of histones in that region must be low, 
allowing ready access to the naked DNA.  
A complex network of histone modifying proteins regulates the level of chromatin 
condensation (see Chapter 4 – The role of nucleosomes in epigenetic gene 
regulation for further details). Two key regulators are histone acetyltransferases 
(HATs) and histone deacetylases (HDACs). HATs add acetyl groups (CH3CO (Ac)) 
while HDACs remove these from specific amino acids on histones (Verdin and Ott 
2014). 
The methylation status of CpGs, and in particular CpG islands, determines the 
acetylation status of localized histones which, in turn, regulates the condensation of 
that region of chromatin, the accessibility of associated promoters and thus regulates 
gene expression. The mechanism by which this process occurs will be discussed in 
the next section. 
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2. Readers of methylcytosine: DNA methylation and gene expression   
The methylation status of CpGs can be read by three types of interacting proteins, 
these are 1) The methyl-CpG binding domain protein (MBD) family, 2) The Kaiso 
proteins and Kaiso-like proteins and 3) The UHRF proteins (Ubiquitin-like with PHD 
and ring finger domains). As the name suggests, the MBD family of proteins binds to 
regions containing double stranded methylated CpG (5-mCpG) via a conserved 
binding domain (Nan et al. 1993), while the Kaiso and Kaiso-like proteins bind to 
methylated DNA via zinc finger motifs (Prokhortchouk et al. 2001; Filion et al. 2006). 
Both the MDB and Kaiso/Kaiso-like proteins repress the transcription of the DNA 
region they bind to (Hendrich and Bird 1998; Filion et al. 2006). However, the 
manner in which they target DNA is slightly different; Kaiso proteins bind to two 
consecutive methylated CpG sites whereas the MBD proteins preferentially bind to 
single CpG dinucleotides (Daniel et al. 2002; Sasai et al. 2010). UHRF proteins do 
not repress transcription, they are involved in ensuring both strands of DNA maintain 
5-mCpG patterns during DNA replication; UHRF proteins bind to hemimethylated 
DNA (DNA where a CpG cytosine is methylated on only one strand of double 
stranded DNA) and recruit the DNA methyltransferase DNMT1 to that location 
(Bostick et al. 2007; Sharif et al. 2007). See Section 3 -  Writers of methylcytosine: 
DNA methyltransferases (DNMTs) within this chapter for further details regarding the 
role of DNMTs.  
2.1 Methyl-CpG binding domain proteins (MBD) 
The MDB family comprises 7 proteins; MeCP2 (methyl-CpG-binding protein 2), 
MBD1, MBD2, MBD3, MBD4, MBD5 and MBD6 (Hendrich and Bird 1998; Baymaz et 
al. 2014). All of these proteins bind directly to methylated DNA (via a 60-85 amino 
acid (aa) MBD domain). MeCP2, MBD1 and MBD2 also bind to transcriptional 
5 
 
repressors via a transcriptional repression domain (TRD) (Wolffe et al. 1999; Boeke 
et al. 2000), while MBD3 interacts with transcriptional repressor proteins via a C-
terminal coiled-coiled domain (Hendrich and Bird 1998) (Figure 4). MDB proteins can 
bind to different yet overlapping partner proteins via their TRD. A key family of 
transcriptional repressors is the histone deacetylases (HDAC1, 2 and 3). These 
HDACs can bind to MeCP2 and MBD1-3 (Ng et al. 1999; Kokura et al. 2001; Saito 
and Ishikawa 2002; Shyh-Chang et al. 2013; Lyst et al. 2013). By bringing HDACs 
and other histone-modifying molecules to regions of methylated DNA, MBD proteins 
can direct the formation of heterochromatin. Heterochromatin consists of highly 
condensed chromatin that is often inaccessible to the transcriptional machinery and 
associated with low levels of acetylation (due to the activity of HDACs bound to 
MBD-proteins) (Taddei et al. 2001) at histone H3 on lysine residues 9, 14 and 18, 
and histone H4 on lysine residue 16 (Verdin and Ott 2014). In contrast, these regions 
often contain high levels of methyl groups on specific histones, such as histone H3 
methylation on lysine 9 (Fuks et al. 2003)). MeCP2, MBD1 and MBD2 bind to histone 
methyltransferase proteins (SUV39H1, SETDB1 and PRMT5) (Lunyak et al. 2002; 
Fujita et al. 2003; Sarraf and Stancheva 2004; Le Guezennec et al. 2006) which 
facilitate the methylation of local histones (for further information regarding MDBs 
and their binding partners see Du et al. 2015). Heterochromatin is initiated by the 
juxtaposition of individual nucleosomes into dense nucleosome arrays by 
nucleosome remodeling complexes (see Chapter 4 – The role of nucleosomes in 
epigenetic gene regulation for further details). Two of these complexes are NuRD/Mi-
2 (a nucleosome remodeling complex with histone deacetylase activity (conferred by 
HDAC1 and HDAC2) (Xue et al. 1998) and the SWI/SNF ATP-dependent chromatin 
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remodeling complex BAF (for a general review of SWI/SNF complexes see Kadoch 
and Crabtree 2015). 
MeCP2 binds to the BAF complex by the BRM (also known as SMARCA2) subunit 
(Harikrishnan et al. 2005) and MBD2 and 3 bind to the NuRD/Mi-2 complex (Ramírez 
et al. 2012; Baubec et al. 2013). Thus, the recognition of methylated DNA by MeCP2 
and MBD1 and 3 results in modification of local histones (deacetylation and 
methylation). This facilitates the binding of nucleosome-remodeling protein 
complexes (also directed to that location by MBD proteins) and the remodeling of 
nucleosomes to reduce accessibility. This decrease in accessibility closes access to 
the local DNA for transcription factors and RNA polymerase, resulting in 
transcriptional silencing.  
MBD4 does not play a significant role in transcription repression. Rather, it contains 
a glycosylase domain that facilitates mismatch repair (mC>T or C>U) at CpG 
dinucleotides (Hendrich et al. 1999; Petronzelli et al. 2000). Both MBD5 and 6 
remain to be fully characterized; despite containing MBD domains, there is no 
evidence that they bind to methylated DNA (Laget et al. 2010). However, they do 
bind to the human polycomb deubiquitinase complex (PR-DUB) which removes 
ubiquitin from Histone H2AK119 (Baymaz et al. 2014). 
 
3. Writers of methylcytosine: DNA methyltransferases (DNMTs) 
Humans possess five DNA methyltransferase enzymes (DNMTs); DNMT1, DNMT2, 
DNMT3A, DNMT3B and DNMT3L. Of these, DNMT1, DNMT3A and DNMT3B add 
methyl groups to cytosine bases at CpG dinucleotides within DNA (Lyko 2017) using 
S‑adenosylmethionine as the methyl donor (Du et al. 2016). DNMT1, DNMT3A and 
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DNMT3B contain a C-terminal catalytic domain responsible for methylating CpGs 
and varying N-terminal regulatory domains (Denis et al. 2011) (Figure 5). Although 
DNMT2 and DNMT3L share high levels of conservation with the other DNMTs, they 
do not possess catalytic domains capable of methylating CpG dinucleotides and 
have smaller N-terminal regulatory domains (Aapola et al. 2000; Dong et al. 2001). 
DNMT2 methylates a small subset of tRNAs (Legrand et al. 2017) and DNMT3L can 
bind to DNMT3A to form heterotetramers (2 DNMT3A molecules and 2 DNMT3L 
molecules). These heterotetramers have increased catalytic activity compared to 
DNMT3A monomers (Jia et al. 2007).  
 
3.1 The function of DNMTs: maintenance methylation  
As described in section 2 of this chapter, many of the readers of DNA methylation 
only recognise fully methylated double stranded CpG dinucleotides in which the 
cytosine bases on both strands must be methylated. To maintain methylation during 
DNA replication, each newly synthesised daughter DNA strand must be methylated 
using the original methylated DNA strand as a template. This maintenance 
methylation is the principal role of DNMT1 (Bestor et al. 1988; Li et al. 1992). 
DNMT1 is directed to the replication fork during S phase by binding to HDAC2 and 
DNA methyltransferase-associated protein 1 (DMAP1) (Rountree et al. 2000). 
DNMT1 also binds to PCNA (proliferating cell nuclear antigen) (Chuang et al. 1997) 
and DNA directly at the replication fork (Suetake et al. 2006). Once at the replication 
fork, DNMT1 recognises hemimethylated DNA by directly interacting with the UHRF 
proteins (Bostick et al. 2007; Sharif et al. 2007; Berkyurek et al. 2014). Once DNMT1 
is in position, its catalytic domain covers the hemimethylated DNA region and both 
the selection of the cytosine for methylation and the process of methylation occurs 
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within the catalytic domain (Song et al. 2012; Bashtrykov et al. 2012). In addition to 
this maintenance methylation, DNMT1 (and DNMT3B) can facilitate de novo 
methylation of promoter regions via interactions with MBD3-NuRD/Mi-2 complexes 
(Cai et al. 2014). 
 
3.2 The function of DNMTs: establishment of DNA methylation  
Appropriate DNA methylation in mammalian germ cells is essential for fertility and 
the viability of the resulting embryo (Messerschmidt et al. 2014). Primordial oocyte 
cells undergo genome-wide demethylation (Seisenberger et al. 2012), then the 
growing oocytes (not yet fertilised) proceed to develop complex, organised DNA 
methylation patterns. During this period CpG islands associated with maternally 
imprinted genes are also methylated. This de novo methylation is carried out by 
DNMT3/DNMT3L complexes (Okano et al. 1998; Okano et al. 1999) and appears to 
be associated with histone modifications such as histone 3 lysine 36 trimethylation 
(H3K36me3) that are associated with transcriptional activity, suggesting that 
transcriptional activity is required in the non-dividing oocyte prior to gene silencing 
(Smallwood et al. 2011; Stewart et al. 2015). However, the precise timing and 
manner in which these enzymes are directed to specific regions of the oocyte 
genome remains to be fully clarified. Mammalian sperm cells also have distinct 
patterns of DNA methylation. However, unlike oocytes, as sperm progenitor cells 
undergo repeated mitoses at the onset of puberty the activity of DNMT1 is required 
to maintain the pattern of methylation (Marques et al. 2011). Shortly after fertilisation 
the embryonic genome undergoes a wave of demethylation (Sasaki and Matsui 
2008) (see Section 4 in this chapter for mechanistic details of DNA demethylation). 
The unmethylated DNA of the embryo is then re-methylated by DNMT3/DNMT3L 
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complexes. DNMT3/DNMT3L methylate DNA in a non-selective manner, they have a 
preference for CpG dinucleotides but can also methylate CpH (H=A, C or T) 
dinucleotides (Gowher and Jeltsch 2001). Recent advanced in sequencing 
technology has enabled the identification of frequent CpH methylation in embryonic 
stem cells and neurones (Lister et al. 2009; Ziller et al. 2011). Differences in cell-
specific levels of CpH methylation appears to be a consequence of differential 
expression of DNMT3a and DNMT3b (Lee et al. 2017). The mechanism that 
determines which DNA sequences are de novo methylated by DNMT3/DNMT3L is 
unclear. However, it is known that, in addition to preferentially methylating CpG 
dinucleotides, this is influenced by the surrounding sequence; CpGs with purine 
bases on the 5’ flank and pyrimidines on the 3’ flank are preferentially methylated 
(Lin et al. 2002). DNMT3 binds directly to histone H3 tails (Ooi et al. 2007) and this 
binding allosterically activates DNMT3 resulting the methylation of DNA local to that 
histone (Guo et al. 2014b; Baubec et al. 2015). The presence of large modifications 
on H3K4 (tri-methylation or acetylation) prevents binding of DNMT3 and associated 
DNA methylation (Ooi et al. 2007). Genome wide-methylation studies have shown a 
strong correlation between the absence of H3K4me3 and DNA methylation (Weber 
et al. 2007; Meissner et al. 2008) suggesting that this mechanism is important in 
setting global DNA methylation patterns. DNMT3 also binds to histone H3 when it is 
trimethylated at lysine 36 (H3K36me3). This histone mark is found in gene bodies 
and at exon-intron boundaries and correlates to transcriptionally active regions. The 
presence of H3K36me3 is also inversely correlated to H3K4me3 (Vakoc et al. 2006; 





3.3 CpG Islands 
As described previously, CpG island are CpG-rich regions that are associated with 
the promoter region of approximately 70% of human genes. The majority of these 
CpG islands are not methylated during early embryogenesis, and are associated 
with a histone H3 modifications (H3K27me3 and H3K4me3); H3K27me3 marked 
regions of DNA are prone to undergo methylation during differentiation and 
oncogenesis (Ohm et al. 2007). The presence of transcription factors at regions of 
active transcription is associated with the absence of DNA methylation. This was 
observed more than 20 years ago (Brandeis et al. 1994; Macleod et al. 1994; Han et 
al. 2001) and more recently has been further validated by Genome-Wide Association 
Studies (GWAS) indicating that promoter region variations (and associated changes 
in transcription factor binding) correlated with changes in localised DNA methylation  
(Gutierrez-Arcelus et al. 2013). These results suggest that the cell-specific 
differential presence of transcription factors plays a significant role in determining the 
methylation status and chromatin pattern of different cell types during 
embryogenesis. By the blastocyst implantation stage of development the expression 
of DNMT3A, B and L is reduced and the expression of DNMT1 is increased (Huntriss 
et al. 2004; Vassena et al. 2005; Uysal et al. 2015). At this point cell type-specific 
methylation patterns have been set and are now maintained through repeated 
rounds of mitosis.    
 
4. Erasers of methylcytosine 
There are two main processes that lead to the demethylation of DNA; the first is 
passive demethylation, where the absence or low expression of the maintenance 
methyltransferase DNMT1 results in a dilution of DNA methylation marks as the 
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genome replicates. This results in regions of hemimethylated and, ultimately, 
unmethylated DNA. 
As mentioned in section 3.2, methylation marks are removed in a wave of DNA 
demethylation after fertilisation. Both the paternal and maternal component of the 
zygote genome are demethylated via passive dilution through DNA replication and 
an active process involving the TET (Ten-Eleven Translocation) proteins (Guo et al. 
2014a). TET proteins were first identified as being components of a fusion protein, 
found in acute myeloid leukemia, due to a translocation between chromosomes ten 
and eleven (Lorsbach et al. 2003). The TET family of proteins (TET 1, 2 and 3) are 
oxyginases that catalyse the demethylation of 5mC; firstly 5mC is converted to 5-
hydroxymethylcytosine (5hmC), which is then converted to 5-formylcytosine (5fC) 
and finally to 5-carboxylcytosine (5caC). All three TET enzymes are capable of 
catalysing each of these steps (Kriaucionis and Heintz 2009; Tahiliani et al. 2009; Ito 
et al. 2010; Ito et al. 2011). The resulting 5fC or 5caC is recognised by thymine DNA 
glycosylase (TDG) and is restored by base excision repair (BER) (He et al. 2011). 
TDG excised the 5fC or 5caC resulting in an abasic site that is converted to a single 
strand break. DNA polymeraseβ (Polβ) then inserts a deoxycytidine monophosphate 
at the break and the double stranded DNA is restored by DNA ligase 3 (Weber et al. 
2016). This active modification–active removal (AM–AR) is independent of DNA 
replication (Kohli and Zhang 2013). The 5mC oxidative derivative can also remain 
incorporated in the genome and be converted to unmethylated cytosines by 
replicative dilution. This can occur in the presence of DNMT1 as it does not have a 
high affinity for 5hmC:C, 5fC:C and 5caC:C (Hashimoto et al. 2012; Ji et al. 2014). 
In addition to demethylating genomes during embryogenesis, the TET proteins play 
important roles in determining pluripotency cell differentiation: Recent knockout 
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experiments in mouse embryonic stem cells have shown that loss of TET1 or TET2 
reduce the level of 5hmC and alter gene transcription. With unique targets being 
identified for each protein, the resulting gene expression changes have been 
suggested to influence differentiation potential of these stem cells (Koh et al. 2011; 
Huang et al. 2014). 
 
 
4.1 Regulation of DNA demethylation by TET enzymes 
 
TET protein activity requires α-KG and oxygen as substrates and Fe(II) as a 
cofactor. The availability of these molecules can influence the activity of the TET 
catalysed reaction (Lu et al. 2015). α-KG is generated in the citric acid cycle by the 
activity of isocitrate dehydrogenase (IDH1, 2, 3). Upregulation of IDH results in the 
production of excess α-KG and an associated increase of 5hmC throughout the 
genome, whereas loss of function mutations in IDH result in reduced α-KG 
production and are associated with increased levels of genomic methylation 
(Losman and Kaelin 2013). Similarly, fumarate and succinate can accumulate in 
tumour cells following disruption of the citric acid cycle and these molecules compete 
with α-KG, resulting in reduced TET activity (Laukka et al. 2016).  
 
TET proteins are found to localise preferentially to CpG islands and transcriptionally 
active promoters, this is facilitated in part, by DNA binding domains that preferentially 
bind CpG rich regions, and in part due to interactions with other binding partners 
such as the pluripotency factor NANOG (Costa et al. 2013) and Polycomb repressive 




In certain tissues the levels of 5mC oxidative derivatives are relatively high, 
suggesting that they have functional roles beyond being intermediates for 
demethylation. Moreover, the balance between the activity of DNA 
methyltransferases and the demethylation machinery is delicate, and when an 
imbalance occurs, either during development or in somatic cells, disease can result.  
Further details on 5mC oxidation, as well as examples of mutations in the 
methylation machinery that result in disease, are discussed in Chapter 3 – 




In the mammalian cell, there is a delicate balance being held between DNA 
modifying enzymes, the writers and erasers of methylcytosine. During 
embryogenesis the timing and molecular positioning of demethylation and then re-
methylation is orchestrated with incredible precision to facilitate appropriate 
differentiation. Once tissue differentiation has occurred these epigenetic marks are 
maintained or, in some tissue types, progressively change. In many ways, these 
simple markers are relatively easy to understand and molecular techniques allow us 
to analyse them at ever increasing speed and throughput. However, there is still 
much to discover, in particular how these molecules are regulated and interact with 
each other and how DNA modifying and binding molecules interact with histone 
modifying and binding molecules to determine chromatin structure and cell specific 
gene expression. Discovering the mode of these interactions will be important for 





Figure 1. 5-methylcytosine occurs primarily within the context of a CpG 
dinucleotide. A, Shown are two complementary (base-paired) antiparallel strands of 
DNA containing a CpG dinucleotide, where ‘p’ represents the sugar-phosphate 
backbone linked through phosphodiester bonds (shaded grey). In this example, the 
molecule contains 5-methylcytosine (dashed circled). Note that the sequence is 
palindromic (CG:GC), that each strand is read in the 5’ to 3’ direction and that 5-
methylcytosine is present on both strands. B, Methylation of cytosine occurs at the 
5th atom of the 6-atom ring resulting in the formation of 5-methylcytosine. 
 
Figure 2. Spontaneous deamination of 5-methylcytosine to thymine as a 
source of C to T transitions. The pyrimidine bases cytosine and thymine differ by 
virtue of a primary amine group (cytosine) or a carbonyl group (thymine) at the 4th 
carbon. Methylation of cytosine at the 5th atom of the 6-atom ring followed by 
deamination results in thymine.  
 
Figure 3. CpG and methyl-CpG distribution. CpG dinucleotides are more 
abundant in regions called CpG islands, which are found in the promoter regions of a 
subset of genes and in non-genic sequences such as repeat elements. In normal 
cells, the promoter regions of expressed genes are usually unmethylated (white 
circles), though it should be noted that an absence of methylation does not imply the 
gene is actually expressed. Conversely, methylation within a gene promoter region is 
not conducive to gene expression. CpG dinucleotides within the body of highly 
expressed genes are usually methylated, whereas those in weakly or non-expressed 
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genes are often unmethylated. CpG dinucleotides in repeat elements and 
transposable elements are methylated to ensure they remain transcriptionally silent. 
 
Figure 4. The conserved functional domains of the methyl-binding domain 
proteins MeCP2, MBD1, MBD2, MBD3, MBD4, MBD5 and MBD6. All members of 
the methyl-binding domain family of proteins contain a methyl-CpG-binding domain 
(MBD) that facilitates binding to methylated DNA. MBD1 also contains CxxC 
domains that enables the binding of unmethylated CpG regions. MeCP2, MBD1 and 
MBD2 contain transcription repression domains (TDR) these regions bind to proteins 
that confer transcriptional repression, most notably HDAC1, 2, and 3. MBD2 and 
MBD3 contain coiled-coiled domains (CC) that facilitate transcriptional repression 
through the binding of HDACs and other histone modifying proteins such as 
NuRD/Mi-2. MBD4 does not contain domains involved in transcriptional repression, it 
possesses a glycosylase domain that facilitates mismatch repair at CpG 
dinucleotides. Protein size is given in amino acids (aa) and represents the size of the 
human homologue. 
  
Figure 5. The conserved functional domains of the DNA methyltransferase 
proteins DNMT1, DNMT2, DNMT3A, DNMT3B and DNMT3L. All members of the 
DNMT family share a conserved C-terminal catalytic methyltransferase domain 
(MTase). DNMT1 contains several conserved N-terminal regions including the DNA 
methyltransferase associated protein 1 interacting domain (DMAPD) that interact 
with the transcriptional repressor DMAP1 and also HDAC2, the PCDNA binding 
domain (PDB), the replication foci targeting domain (RFTD) and a CxxC domain that 
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facilitates binding to unmethylated DNA. DNMT3A and DNMT3B contain Pro-Trp-
Trp-Pro (PWWP) and ATRX-DNMT3-DNMT3L (ADD) domains, which interact with 
the N-terminal tails of histones. The ADD domain, which is conserved in DNMT3L, 
also facilitates binding to other regulatory proteins. Protein size is given in amino 
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